{"id":"https://openalex.org/W2743936472","doi":"https://doi.org/10.1016/j.ejca.2017.07.003","title":"Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis","display_name":"Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis","alternate_titles":[],"publication_year":2017,"publication_date":"2017-08-08","ids":{"openalex":"https://openalex.org/W2743936472","doi":"https://doi.org/10.1016/j.ejca.2017.07.003","mag":"2743936472","pmid":"https://pubmed.ncbi.nlm.nih.gov/28800492","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5630199"},"language":"en","primary_location":{"id":"doi:10.1016/j.ejca.2017.07.003","doi":"https://doi.org/10.1016/j.ejca.2017.07.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2017.07.003","pdf_url":"http://www.ejcancer.com/article/S0959804917311103/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2743936472"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"http://www.ejcancer.com/article/S0959804917311103/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090669536","display_name":"Larysa H. M. Rydzewska","orcid":"https://orcid.org/0000-0001-6205-7457","observed_orcids":["https://orcid.org/0000-0001-6205-7457"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Larysa H.M. Rydzewska","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: larysa.rydzewska@ucl.ac.uk","MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":"https://orcid.org/0000-0001-6205-7457","affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK. Electronic address: larysa.rydzewska@ucl.ac.uk","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]},{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058930148","display_name":"Sarah Burdett","orcid":"https://orcid.org/0000-0001-8687-2851","observed_orcids":["https://orcid.org/0000-0001-8687-2851"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sarah Burdett","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045701481","display_name":"Claire Louise Vale","orcid":"https://orcid.org/0000-0001-5157-0634","observed_orcids":["https://orcid.org/0000-0001-5157-0634"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claire L. Vale","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065195021","display_name":"Noel William Clarke","orcid":"https://orcid.org/0000-0001-7776-8059","observed_orcids":["https://orcid.org/0000-0001-7776-8059"]},"institutions":[{"id":"https://openalex.org/I2801120809","display_name":"Salford Royal NHS Foundation Trust","ror":"https://ror.org/019j78370","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801120809","https://openalex.org/I4405259061"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Noel W. Clarke","raw_affiliation_strings":["Salford Royal NHS Foundation Trust, Salford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Salford Royal NHS Foundation Trust, Salford, UK","institution_ids":["https://openalex.org/I2801120809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007779528","display_name":"Karim S. Fizazi","orcid":"https://orcid.org/0000-0002-6068-9474","observed_orcids":["https://orcid.org/0000-0002-6068-9474"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Karim Fizazi","raw_affiliation_strings":["Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave-Roussy, University of Paris Sud, 114 Rue Edouard Vaillant, Villejuif 94800, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2801843802"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060580174","display_name":"Thian San Kheoh","orcid":"https://orcid.org/0009-0009-0719-8631","observed_orcids":["https://orcid.org/0009-0009-0719-8631"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thian Kheoh","raw_affiliation_strings":["Janssen Research & Development, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032518609","display_name":"Malcolm David Mason","orcid":"https://orcid.org/0000-0003-1505-2869","observed_orcids":["https://orcid.org/0000-0003-1505-2869"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Malcolm D. Mason","raw_affiliation_strings":["Cardiff University, School of Medicine, Cardiff, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University, School of Medicine, Cardiff, UK","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010579236","display_name":"Branko Miladinovi\u0107","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Branko Miladinovic","raw_affiliation_strings":["Janssen Research & Development, San Diego, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, San Diego, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022378006","display_name":"Nicholas David James","orcid":"https://orcid.org/0000-0002-7314-8204","observed_orcids":["https://orcid.org/0000-0002-7314-8204"]},"institutions":[{"id":"https://openalex.org/I2799307867","display_name":"Queen Elizabeth Hospital Birmingham","ror":"https://ror.org/048emj907","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1308923049","https://openalex.org/I2799307867"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicholas D. James","raw_affiliation_strings":["Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK","Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK","Queen Elizabeth Hospital, Birmingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK; Queen Elizabeth Hospital, Birmingham, UK","institution_ids":["https://openalex.org/I2799307867","https://openalex.org/I79619799"]},{"raw_affiliation_string":"Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK","institution_ids":["https://openalex.org/I79619799"]},{"raw_affiliation_string":"Queen Elizabeth Hospital, Birmingham, UK","institution_ids":["https://openalex.org/I2799307867"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014097745","display_name":"Mahesh Parmar","orcid":"https://orcid.org/0000-0003-0166-1700","observed_orcids":["https://orcid.org/0000-0003-0166-1700","https://orcid.org/0000-0002-8883-424X"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mahesh K.B. Parmar","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110074922","display_name":"Melissa Ruth Spears","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melissa R. Spears","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002909668","display_name":"Christopher J. Sweeney","orcid":"https://orcid.org/0000-0002-0398-6018","observed_orcids":["https://orcid.org/0000-0002-0398-6018"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Christopher J. Sweeney","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059261043","display_name":"Matthew Robert Sydes","orcid":"https://orcid.org/0000-0002-9323-1371","observed_orcids":["https://orcid.org/0000-0002-9323-1371"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Matthew R. Sydes","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028207252","display_name":"NamPhuong Tran","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"NamPhuong Tran","raw_affiliation_strings":["Janssen Research & Development, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, Los Angeles, CA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048264018","display_name":"Jayne F. Tierney","orcid":"https://orcid.org/0000-0002-4734-3014","observed_orcids":["https://orcid.org/0000-0002-4734-3014"]},"institutions":[{"id":"https://openalex.org/I4210091428","display_name":"MRC Clinical Trials Unit at UCL","ror":"https://ror.org/001mm6w73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I124357947","https://openalex.org/I4210087105","https://openalex.org/I4210091428","https://openalex.org/I45129253","https://openalex.org/I90344618"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jayne F. Tierney","raw_affiliation_strings":["MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MRC Clinical Trials Unit at UCL, Aviation House, 125 Kingsway, London WC2B 6NH, UK","institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":10,"corresponding_author_ids":["https://openalex.org/A5048264018","https://openalex.org/A5090669536"],"corresponding_institution_ids":["https://openalex.org/I4210091428","https://openalex.org/I45129253"],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":{"value":2708,"currency":"EUR","value_usd":2920},"fwci":2.4465,"has_fulltext":true,"cited_by_count":172,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.93238771,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"84","issue":null,"first_page":"88","last_page":"101"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abiraterone-acetate","display_name":"abiraterone","score":0.9290000200271606},{"id":"https://openalex.org/keywords/androgen-deprivation-therapy","display_name":"androgen deprivation therapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/metastatic-hormone-sensitive-prostate-cancer","display_name":"metastatic hormone-sensitive prostate cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7749999761581421},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9980000257492065},{"id":"https://openalex.org/keywords/acute-toxicity","display_name":"acute toxicity","score":0.621999979019165},{"id":"https://openalex.org/keywords/latitude-trial","display_name":"LATITUDE trial","score":0.7609999775886536},{"id":"https://openalex.org/keywords/stampede-trial","display_name":"STAMPEDE trial","score":0.9950000047683716},{"id":"https://openalex.org/keywords/docetaxel","display_name":"docetaxel","score":0.6850000023841858}],"concepts":[{"id":"https://openalex.org/C2775832370","wikidata":"https://www.wikidata.org/wiki/Q27888393","display_name":"Abiraterone acetate","level":5,"score":0.8826680183410645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8267214894294739},{"id":"https://openalex.org/C2777899217","wikidata":"https://www.wikidata.org/wiki/Q4759439","display_name":"Androgen deprivation therapy","level":4,"score":0.751880943775177},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7093824148178101},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6839243769645691},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6423930525779724},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.5860351920127869},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4904327094554901},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4585970938205719},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.44843900203704834},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4441976845264435},{"id":"https://openalex.org/C2780275930","wikidata":"https://www.wikidata.org/wiki/Q1628266","display_name":"Hormone therapy","level":4,"score":0.4339357912540436},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34540557861328125},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1538843810558319},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.12528768181800842}],"mesh":[{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000726","descriptor_name":"Androgen Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000736","descriptor_name":"Androstenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000736","descriptor_name":"Androstenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D011239","descriptor_name":"Prednisolone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016009","descriptor_name":"Chi-Square Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016017","descriptor_name":"Odds Ratio","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D060787","descriptor_name":"Neoplasm Grading","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.ejca.2017.07.003","doi":"https://doi.org/10.1016/j.ejca.2017.07.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2017.07.003","pdf_url":"http://www.ejcancer.com/article/S0959804917311103/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5630199","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5630199/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eur J Cancer","raw_type":"Text"},{"id":"pmid:28800492","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28800492","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Journal Article"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:104938","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/id/eprint/104938/1/Adding%20abiraterone%20to%20androgen%20deprivation%20therapy%20in.pdf","pdf_url":"https://orca.cardiff.ac.uk/id/eprint/104938/1/Adding%20abiraterone%20to%20androgen%20deprivation%20therapy%20in.pdf","source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:eprints.ucl.ac.uk.OAI2:1570360","doi":null,"is_oa":false,"landing_page_url":"https://discovery.ucl.ac.uk/id/eprint/1570360/","pdf_url":null,"source":{"id":"https://openalex.org/S4306400024","display_name":"UCL Discovery (University College London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I45129253","host_organization_name":"University College London","host_organization_lineage":["https://openalex.org/I45129253"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"European Journal of Cancer , 84 pp. 88-101. (2017)","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1016/j.ejca.2017.07.003","doi":"https://doi.org/10.1016/j.ejca.2017.07.003","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.ejca.2017.07.003","pdf_url":"http://www.ejcancer.com/article/S0959804917311103/pdf","source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[{"id":"https://openalex.org/G5951394679","display_name":"CANCER: Trials with potential global reach and other challenging trials","funder_award_id":"MC_UU_12023/28","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"},{"id":"https://openalex.org/G6731147368","display_name":null,"funder_award_id":"MC_UU_12023/25","funder_id":"https://openalex.org/F4320334626","funder_display_name":"Medical Research Council"}],"funders":[{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2743936472.pdf","grobid_xml":"https://content.openalex.org/works/W2743936472.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W1546847154","https://openalex.org/W1596902544","https://openalex.org/W1598602811","https://openalex.org/W1939260248","https://openalex.org/W1966953116","https://openalex.org/W1994047807","https://openalex.org/W2049192772","https://openalex.org/W2050118439","https://openalex.org/W2108247235","https://openalex.org/W2110534364","https://openalex.org/W2126930838","https://openalex.org/W2132850027","https://openalex.org/W2172161665","https://openalex.org/W2210989209","https://openalex.org/W2314600973","https://openalex.org/W2588179146","https://openalex.org/W2593708391","https://openalex.org/W2600996424","https://openalex.org/W2620746860","https://openalex.org/W2620798309","https://openalex.org/W2664930764","https://openalex.org/W2737212161","https://openalex.org/W2743350540","https://openalex.org/W2948082927","https://openalex.org/W4232838246","https://openalex.org/W6698804469"],"related_works":["https://openalex.org/W2789351461","https://openalex.org/W2789828078","https://openalex.org/W2805604514","https://openalex.org/W2913668432","https://openalex.org/W2890444045","https://openalex.org/W2792087716","https://openalex.org/W2778255532","https://openalex.org/W2803151605","https://openalex.org/W4389037074","https://openalex.org/W3189148457"],"abstract_inverted_index":{"Background":[0],"There":[1,323,353],"is":[2,381,421],"a":[3,231,264,281,316,328,382],"need":[4,409],"to":[5,19,36,47,73,219,315,379,394,410],"synthesise":[6],"the":[7,15,38,59,85,120,149,165,174,204,237,289,309,331,344,347,403],"results":[8,78,118],"of":[9,17,40,94,123,129,151,195,215,239,291,311,327,346,371,413],"numerous":[10],"randomised":[11,218],"controlled":[12],"trials":[13,63,96,105,184,207],"evaluating":[14],"addition":[16,310],"therapies":[18],"androgen":[20],"deprivation":[21],"therapy":[22],"(ADT)":[23],"for":[24,53,88,104,119,148,164,173,387,396,402,425],"men":[25,113,217,388,397],"with":[26,70,114,241,308,364,389],"metastatic":[27],"hormone-sensitive":[28],"prostate":[29],"cancer":[30],"(mHSPC).":[31],"This":[32],"systematic":[33],"review":[34,60],"aims":[35],"assess":[37],"effects":[39,150,166,175],"adding":[41],"abiraterone":[42],"acetate":[43],"plus":[44,108,153,221,243,366],"prednisone/prednisolone":[45],"(AAP)":[46],"ADT.":[48],"Methods":[49],"Using":[50],"our":[51],"framework":[52],"adaptive":[54],"meta-analysis":[55,90],"(FAME),":[56],"we":[57,82,278],"started":[58],"process":[61],"before":[62],"had":[64],"been":[65],"reported":[66],"and":[67,91,134,137,157,170,210,283,361,424],"worked":[68],"collaboratively":[69],"trial":[71,77,143],"investigators":[72],"anticipate":[74],"when":[75],"eligible":[76,192],"would":[79],"emerge.":[80],"Thus,":[81],"could":[83],"determine":[84],"earliest":[86],"opportunity":[87],"reliable":[89],"take":[92],"account":[93],"unavailable":[95],"in":[97,112,227,236,268,273,288,330],"interpreting":[98],"results.":[99],"We":[100,116,189],"searched":[101],"multiple":[102],"sources":[103],"comparing":[106],"AAP":[107,152,220,242,365,378],"ADT":[109,111,154,222,224,244,367,380],"versus":[110,223],"mHSPC.":[115],"obtained":[117],"primary":[121],"outcome":[122],"overall":[124],"survival":[125,132],"(OS),":[126],"secondary":[127],"outcomes":[128],"clinical/radiological":[130,292],"progression-free":[131],"(PFS)":[133],"grade":[135,138,356],"III\u2013IV":[136,357],"V":[139],"toxicity":[140,169],"direct":[141],"from":[142,203],"teams.":[144],"Hazard":[145],"ratios":[146],"(HRs)":[147],"on":[155,167,176],"OS":[156,177,332],"PFS,":[158],"Peto":[159],"Odds":[160],"Ratios":[161],"(Peto":[162],"ORs)":[163],"acute":[168,358],"interaction":[171],"HRs":[172],"by":[178,334,351],"patient":[179],"subgroups":[180],"were":[181,354],"combined":[182],"across":[183,276],"using":[185],"fixed-effect":[186],"meta-analysis.":[187],"Findings":[188],"identified":[190],"three":[191],"trials,":[193,277],"one":[194],"which":[196,412],"was":[197,324],"still":[198],"recruiting":[199],"(PEACE-1":[200],"(NCT01957436)).":[201],"Results":[202],"two":[205,415],"remaining":[206],"(LATITUDE":[208],"(NCT01715285)":[209],"STAMPEDE":[211],"(NCT00268476)),":[212],"representing":[213],"82%":[214],"all":[216],"(without":[225],"docetaxel":[226,395],"either":[228],"arm),":[229],"showed":[230],"highly":[232,284],"significant":[233,285],"38%":[234],"reduction":[235,287],"risk":[238,290],"death":[240],"(HR":[245,294],"=":[246,252,255,295,299,302],"0.62,":[247],"95%":[248,297],"confidence":[249],"interval":[250],"[CI]":[251],"0.53\u20130.71,":[253],"p":[254,301],"0.55":[256],"\u00d7":[257,304],"10":[258,305],"\u221210":[259],"),":[260],"that":[261,313],"translates":[262,314],"into":[263],"14%":[265],"absolute":[266,318],"improvement":[267,319],"3-year":[269],"OS.":[270],"Despite":[271],"differences":[272],"PFS":[274,293],"definitions":[275],"also":[279],"observed":[280],"consistent":[282],"55%":[286],"0.45,":[296],"CI":[298],"0.40\u20130.51,":[300],"0.66":[303],"\u221236":[306],")":[307],"AAP,":[312],"28%":[317],"at":[320],"3":[321],"years.":[322],"no":[325,369],"evidence":[326],"difference":[329],"benefit":[333,348],"Gleason":[335],"sum":[336],"score,":[337],"performance":[338],"status":[339],"or":[340,374,417],"nodal":[341],"status,":[342],"but":[343,368],"size":[345],"may":[349],"vary":[350],"age.":[352],"more":[355],"cardiac,":[359],"vascular":[360],"hepatic":[362],"toxicities":[363,373],"excess":[370],"other":[372],"death.":[375],"Interpretation":[376],"Adding":[377],"clinically":[383],"effective":[384],"treatment":[385,401],"option":[386],"mHSPC,":[390],"offering":[391],"an":[392],"alternative":[393],"who":[398],"are":[399],"starting":[400],"first":[404],"time.":[405],"Future":[406],"research":[407],"will":[408],"address":[411],"these":[414],"agents":[416],"whether":[418],"their":[419],"combination":[420],"most":[422],"effective,":[423],"whom.":[426]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2743936472","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":12},{"year":2023,"cited_by_count":18},{"year":2022,"cited_by_count":19},{"year":2021,"cited_by_count":20},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":37},{"year":2018,"cited_by_count":26},{"year":2017,"cited_by_count":6}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-08-17T00:00:00"}
